This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: D.e. Shaw Research, LLC, Relay Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 31 
1 out of 14 Years Active: 2026
Title: Kashif Tanveer: Innovator in Pharmaceutical Chemistry
Introduction
Kashif Tanveer is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that target specific enzymes.
Latest Patents
Kashif Tanveer holds a patent for "Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors." This patent relates to innovative compounds and pharmaceutical compositions designed to inhibit the activity of PI3Kα enzymes. The methods described in the patent also address the treatment of disorders associated with PI3Kα signaling.
Career Highlights
Throughout his career, Kashif has worked with prominent companies in the pharmaceutical industry, including Relay Therapeutics, Inc. and D.E. Shaw Research, LLC. His work has focused on advancing therapeutic options through innovative chemical compounds.
Collaborations
Kashif has collaborated with esteemed colleagues such as Alessandro Boezio and Lucian V Dipietro, contributing to a dynamic research environment that fosters innovation.
Conclusion
Kashif Tanveer's work exemplifies the intersection of innovation and pharmaceutical research, showcasing his commitment to developing solutions for complex medical challenges. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile